دورية أكاديمية

Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at 24 weeks: A Posthoc Analysis from ENLIVEN

التفاصيل البيبلوغرافية
العنوان: Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at 24 weeks: A Posthoc Analysis from ENLIVEN
المؤلفون: Loomba, Rohit, Sanyal, Arun J., Gottwald, Mildred D., Feng, Shibao, Tseng, Leo, Hartsfield, Cynthia L., Mansbach, Hank, Margalit, Maya, Bhatt, Deepak L.
المصدر: In Metabolism June 2024 153 Supplement
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00260495
DOI:10.1016/j.metabol.2024.155874